Stratos Wealth Partners’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-12,265
Closed -$1.67M – 1127
2020
Q3
$1.67M Buy
12,265
+7,614
+164% +$810K 0.05% 284
2020
Q2
$449K Sell
4,651
-84
-2% -$7.01K 0.02% 637
2020
Q1
$222K Buy
+4,735
New +$303K 0.01% 779

Stratos Wealth Partners's MYOK Position: Q4 2020 in Review

Stratos Wealth Partners sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 12,265 shares — an estimated $1.67M sold.

Stratos Wealth Partners first reported a position in MYOK in Q1 2020 and held it in 3 quarters. The position peaked at $1.67M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Stratos Wealth Partners reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Stratos Wealth Partners sold 12,265 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $1.67M.
  • Stratos Wealth Partners first reported a position in MyoKardia, Inc. Common Stock in Q1 2020 and held it in 3 quarters.
  • Stratos Wealth Partners's MyoKardia, Inc. Common Stock position peaked at $1.67M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Stratos Wealth Partners's 13F filing for Q4 2020, filed 29 Jan 2021.